Ameriprise
SPRO icon

Ameriprise’s Spero Therapeutics SPRO Stock Holding History

Ameriprise’s Portfolio SPRO Stock Details SPRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-402,963
Closed -$592K – 3951
2023
Q4 		$592K Sell
402,963
-60,678
-13% -$72.3K ﹤0.01% 3384
2023
Q3 		$561K Sell
463,641
-4,319
-0.9% -$5.98K ﹤0.01% 3363
2023
Q2 		$679K Buy
+467,960
New +$801K ﹤0.01% 3324
2022
Q2 		– Sell
-586,642
Closed -$5.1M – 3990
2022
Q1 		$5.1M Buy
586,642
+223,108
+61% +$2.29M ﹤0.01% 2413
2021
Q4 		$5.82M Sell
363,534
-13,561
-4% -$215K ﹤0.01% 2366
2021
Q3 		$6.94M Sell
377,095
-61,742
-14% -$991K ﹤0.01% 2150
2021
Q2 		$6.13M Buy
438,837
+4,049
+0.9% +$56.6K ﹤0.01% 2304
2021
Q1 		$6.4M Buy
434,788
+169,347
+64% +$2.98M ﹤0.01% 2235
2020
Q4 		$5.15M Buy
+265,441
New +$4.14M ﹤0.01% 2253
2020
Q3 		– Sell
-21,454
Closed -$290K – 3780
2020
Q2 		$290K Buy
+21,454
New +$241K ﹤0.01% 3375

Other funds holding SPRO

AFM
Anson Funds Management Dallas, Texas $1.57B AUM 370.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $249M AUM 68.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return